About Mark Currie
Mark Currie is a director at Sea Pharmaceuticals.
Mark Currie reports to the SEC as a director or officer of 2 public companies: Ironwood Pharmaceuticals (IRWD) and Korsana Biosciences (KRSA).
Mark Currie first appears on SEC filings in 2010.
Experience
This experience comes from Mark Currie's profile and from SEC filings. For roles taken from filings, the years are when the filings name Mark Currie in the role, so the role may have started earlier or lasted longer.
PS
Prudentia Sciences Current
Chair SAB
2025 – Present
ST
Scaffold Therapeutics Current
Chair SAB
2025 – Present
IV
Iaso Ventures Current
Venture Partner
2024 – Present
AT
Antag Therapeutics Current
Board Member
2023 – Present
Sea Pharmaceuticals, LLC Current
Member Board Of Directors
2021 – Present · Cambridge, MA
Develops potential oral medicines for people with tinnitus, epilepsy and sporadic ALS.
II
Ironwood Pharmaceuticals Inc. Current
Chief Scientific Officer and director
Director Board Of Directors (2008 – Present)
2008 – Present · Public company (IRWD)
SE
Science Exchange
Director Board Of Directors
2020 – 2025
CY
Cyclerion
Chair of Scientific Advisory Board
2019 – 2025
KI
Korsana Biosciences, Inc.
President and CSO
2019 – 2020 · Public company (KRSA)
MI
Microbia
Chief Science Officer
2002 – 2008
SI
Sepracor Inc
Vice President of Discovery
1999 – 2002
SE
Searle
Senior Director Discovery Pharmacology
1990 – 1999
Key Colleagues at Startups
The people Mark Currie works with at each company, as listed on that company's latest Form D.
Sea Pharmaceuticals, LLC · Form D/A, May 20, 2026
SS
Shaker Sadasivam
Director
JP
James Pearson
President, CEO, CSO, Investor, FTE, Founder and director
NE
Nabil Elkouh
Director
MH
Michael Higgins
Director
WB
Walter Brown
Director
EO
Eric Olson
Director